LONDON (Reuters) - Europe's drugs regulator said on Monday it had established an expert task force on Zika to advise companies working on vaccines and medicines against the virus, which is suspected of causing a spike in birth defects in Brazil.
With no currently approved vaccines or medicines and none even undergoing clinical studies, the move by the London-based European Medicines Agency (EMA) is designed to ensure Zika development work proceeds as rapidly as possible.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!